CYCC - Cyclacel Pharmaceuticals EPS beats by $0.13 May, 12 2020 04:09 PM Cyclacel Pharmaceuticals Inc. Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q1 GAAP EPS of -$2.77 beats by $0.13.Cash and cash equivalents of $8.9MPress ReleaseMore news on: Cyclacel Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,